Regarding "Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma".

MLA

Walker, David A., et al. “Regarding ‘Neuro-Oncology Practice Clinical Debate: Targeted Therapy vs Conventional Chemotherapy in Pediatric Low-Grade Glioma.’” Neuro-Oncology Practice, vol. 7, no. 5, Aug. 2020, pp. 572–73. EBSCOhost, https://doi.org/10.1093/nop/npaa031.

APA

Walker, D. A., Azizi, A. A., Liu, J.-F., Sehested, A., Jaspan, T., Pemp, B., Simmons, I., Ferner, R., Grill, J., Hargrave, D., Driever, P. H., Evans, D. G., & Opocher, E. (2020). Regarding “Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.” Neuro-Oncology Practice, 7(5), 572–573. https://doi.org/10.1093/nop/npaa031

Chicago

Walker, David A, Amedeo A Azizi, Jo-Fen Liu, Astrid Sehested, Timothy Jaspan, Berthold Pemp, Ian Simmons, et al. 2020. “Regarding ‘Neuro-Oncology Practice Clinical Debate: Targeted Therapy vs Conventional Chemotherapy in Pediatric Low-Grade Glioma.’” Neuro-Oncology Practice 7 (5): 572–73. doi:10.1093/nop/npaa031.